Imiquimod vs any other patient‐applied treatment
Any systemic reactions during therapy · AGW in non‐immunocompromised adults
Imiquimod may leads to lower any systemic reactions during therapy compared with any other patient‐applied treatment (low certainty).
1 finding from 1 review
- Imiquimod for anogenital warts in non‐immunocompromised adults 2014 · Cochrane Headline outcomes onlyRR 0.3 [0.09, 0.98]1 study · 60 participantsLow